Zacks Industry Outlook Highlights TechnipFMC, Archrock Inc and Core Laboratories
Despite lower oil prices and weak upstream spending, Zacks sees TechnipFMC, Archrock and Core Laboratories as resilient oilfield services plays.
Here's Why Holding Core Laboratories Stock Is Justified for Now
CLB benefits from revenue expansion, proprietary tools & disciplined spending, though flat guidance, low dividends & sector competition remain headwinds.
Bet on 3 Solid Oilfield Services Stocks Despite Industry Headwinds
Strict capital discipline by upstream energy companies is acting as a dampener, making the outlook for the Zacks Oil and Gas- Field Services industry gloomy. FTI, AROC and CLB are expected to survive the industry challenges.
Williams to Invest $3.1B in Power Projects for Data Centers
WMB commits $3.1 billion to two new power projects, boosting capacity for AI-driven data centers amid record-high electricity demand.
Core Laboratories Stock Rebounds in a Month: Is it Time to Buy?
CLB stock rebounds with 13% gains in a month, outpacing peers and the energy sector as revenues, margins and cash flow strengthen.
Core Laboratories: Not a Buy Yet, But Still Worth Holding On
CLB expands globally with new tech labs and energy transition projects while reducing debt but faces tariff pressures, U.S. market softness and demand volatility risks.
Core Laboratories ( CLB ) Down 21.7% Since Last Earnings Report: Can It Rebound?
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Expand Energy Q2 Earnings & Revenues Miss Estimates, Both Increase Y/Y
EXE's Q2 2025 earnings and revenues miss estimates, but increase year over year, driven by strong production and higher natural gas price realization.
Core Labs Posts Flat Revenue in Q2
Core Laboratories ( NYSE:CLB ) , a specialist in reservoir optimization and production enhancement services for the oil and gas industry, reported its second quarter 2025 earnings on July 23, 2025. GAAP revenue of $130.2 million for Q2 2025 outpaced analyst expectations of $129.1 million, and ...
Core Laboratories Q2 Earnings Beat Estimates, Expenses Increase Y/Y
CLB's second-quarter earnings beat estimates. However, it declined year over year due to the underperformance of the Reservoir Description segment.
Core Laboratories ( CLB ) Beats Q2 Earnings and Revenue Estimates
Core Laboratories (CLB) delivered earnings and revenue surprises of +5.56% and +1.45%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Watch These 4 Energy Stocks for Q2 Earnings: Beat or Miss?
Here's a preview of what to expect from energy stocks EQNR, CLB, OII and PTEN ahead of their quarterly earnings reports, set to be released tomorrow.
Core Laboratories to Post Q2 Earnings: Key Metrics to Watch
CLB's second-quarter revenues are likely to have declined from the year-ago period's level due to weak segment revenues.
Do Options Traders Know Something About Core Laboratories Stock We Don't?
Investors need to pay close attention to CLB stock based on the movements in the options market lately.
Core Lab Stock Plunges 22% in Six Months: Time to Hold or Sell?
CLB struggles with declining revenues, geopolitical risks, margin compression and weak U.S. demand, creating uncertainty around growth and profitability prospects.
SLB Outperforms Industry in 6 Months: What Investors Should Know
SLB shares have dropped 6.5% over the past six months, narrower than the declines seen in peers and the broader sector, with bullish signals and strong global growth drivers.
Why Is Core Laboratories ( CLB ) Down 5.9% Since Last Earnings Report?
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Laboratories Down 30% YTD: Should You Hold or Sell the Stock?
CLB struggles with a 4.4% revenue decline, low ROIC in the first quarter of 2025, minimal dividends and vulnerability to oil price volatility and geopolitical instability.
Williams Companies Q1 Earnings Beat Estimates, Expenses Rise Y/Y
WMB's Q1 earnings show that the Transmission & Gulf of America, Northeast G&P and West segments outperform, but Gas & NGL Marketing Services lags.
Magnolia Q1 Earnings & Revenues Beat Estimates, Expenses Increase Y/Y
MGY's earnings beat estimates and revenues increase year over year, driven by production growth and higher revenues from natural gas and natural gas liquids.
ProPetro Q1 Earnings Beat Estimates, Revenues Decrease Y/Y
PUMP's first-quarter 2025 earnings beat the Zacks Consensus Estimate, driven by a year-over-year decline in costs and expenses.
Expand Energy Q1 Earnings Beat Estimates, Revenues Increase YoY
EXE's Q1 2025 results show earnings and revenue outperformance, driven by strong production and higher price realization.
Core Laboratories Q1 Earnings Miss Estimates, Expenses Increase YoY
CLB's first-quarter earnings miss estimates due to the underperformance of the Reservoir Description segment.
New Strong Sell Stocks for April 24th
AMPY, CARS and CLB have been added to the Zacks Rank #5 (Strong Sell) List on April 24, 2025.
Core Laboratories ( CLB ) Q1 Earnings and Revenues Lag Estimates
Core Laboratories (CLB) delivered earnings and revenue surprises of -6.67% and 0.38%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Halliburton ( HAL ) Q1 Earnings Match Estimates
Halliburton (HAL) delivered earnings and revenue surprises of 0% and 3.04%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Core Laboratories to Post Q1 Earnings: Key Metrics to Watch
CLB's first-quarter revenues are likely to have declined from the year-ago period's level. However, cost reductions are expected to have provided modest relief.
Schlumberger ( SLB ) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Schlumberger (SLB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Core Laboratories ( CLB ) Q1 Earnings Expected to Decline
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's How to Play Core Labs Stock Ahead of Its Q1 Earnings Release
CLB faces declining revenues, weak margins, geopolitical disruptions and inventory issues, with low dividend yield and overvaluation increasing investor caution.
Oceaneering International ( OII ) Surges 13.4%: Is This an Indication of Further Gains?
Oceaneering International (OII) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Tesla To $120? Here Are 10 Top Analyst Forecasts For Wednesday - Ciena ( NYSE:CIEN ) , Arvinas ( NASDAQ:ARVN )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. B. Riley Securities cut Ciena Corporation CIEN price target from $97 to $89. B.
Is Core Stock Worth Buying After a 27% Surge in 6 Months?
CLB stock is supported by international expansion, proprietary tech and solid cash flow amid competitive pricing, volatile oil prices and geopolitical tensions.
Why Is Core Laboratories ( CLB ) Down 16% Since Last Earnings Report?
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Are Options Traders Betting on a Big Move in Core Laboratories ( CLB ) Stock?
Investors need to pay close attention to Core Laboratories (CLB) stock based on the movements in the options market lately.
CLB's Q4 Earnings Beat Estimates, Sales Lag, Expenses Increase
Core Laboratories expects Reservoir Description revenues of $82-$85 million and Production Enhancement revenues of $39-$42 million for the first quarter of 2025.
Core Laboratories ( CLB ) Q4 2024 Earnings Call Transcript
CLB earnings call for the period ending December 31, 2024.
Core Laboratories ( CLB ) Misses Q4 Earnings and Revenue Estimates
Core Laboratories (CLB) delivered earnings and revenue surprises of -4.35% and 1.27%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Core Laboratories to Post Q4 Earnings: Here's What to Expect
CLB is expected to report higher revenues from the year-ago period's level. However, despite this revenue growth, the company is expected to face increased operating expenses.
Baker Hughes ( BKR ) Earnings Expected to Grow: Should You Buy?
Baker Hughes (BKR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Core Laboratories ( CLB ) Reports Next Week: Wall Street Expects Earnings Growth
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Hold Strategy is Apt for Core Laboratories Stock Now
CLB benefits from strong international growth, high-margin projects and an efficient business model. However, stock underperformance, competition and U.S. market challenges pose risks.
Arm Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Astria Therapeutics ( NASDAQ:ATXS ) , ARM Holdings ( NASDAQ:ARM )
U.S. stock futures were mixed this morning, with the Dow futures falling around 0.2% on Monday. Shares of Arm Holdings plc ARM fell sharply in today's pre-market trading after a US jury reportedly found Qualcomm QCOM did not breach Nuvia's license agreement with the company.
Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket - American Battery Tech ( NASDAQ:ABAT )
Shares of Rumble Inc. RUM rose sharply in today's pre-market trading after the company announced it has entered into a definitive agreement for a strategic investment of $775 million from Tether.
Is Now the Right Time to Buy Core Laboratories After Its 12% YTD Rise?
CLB shows strong earnings growth, solid cash flow and innovative technologies, but faces risks from geopolitical tensions, weak U.S. onshore activity and oil price volatility.
Why Is Core Laboratories ( CLB ) Up 11.5% Since Last Earnings Report?
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Laboratories ( CLB ) Q3 2024 Earnings Call Transcript
CLB earnings call for the period ending September 30, 2024.
Core Laboratories' Q3 Earnings and Sales Beat Estimates
CLB expects Reservoir Description revenues of $87.5-$90.5 million and Production Enhancement revenues of $41-$45 million for the fourth quarter of 2024.
Core Laboratories ( CLB ) Q3 Earnings Match Estimates
Core Laboratories (CLB) delivered earnings and revenue surprises of 0% and 1.27%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights ProPetro, Core Laboratories and Oceaneering
ProPetro, Core Laboratories and Oceaneering are included in this Analyst Blog.
